To get a sense of who is truly in control of AbbVie Inc. (NYSE:ABBV), it is important to understand the ownership structure ...

AbbVie Inc. is reiterated as a Strong Buy ahead of Q3 earnings, with revenue growth expected to outpace the sector median.

Learn more about whether AbbVie Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In an era where chronic inflammatory diseases are taking centre stage in healthcare debates, the biologics segment is ...

As markets adjust to higher rates and uneven growth, investors are gravitating towards businesses that balance resilience ...

One of the keys to a comfortable retirement is finding a steady and reliable stream of passive income. But Social Security ...

Today, Allergan Aesthetics, an AbbVie company, announces their continued partnership with Girls Inc. for the 7th year with programming and funding designed to foster mentorship and ensure girls have ...

Baron Health Care Fund gained for the quarter and outperformed its benchmark, the Russell 3000 Health Care Index. Read more ...

The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...

Market OverviewThe Global Anti-Aging Market is projected to grow at a CAGR of approximately 5–6% by 2029. The market’s growth is driven by a rising aging population, rapid technological advancements ...

Meta Platforms, Inc. (NASDAQ:META) is one of the stocks on Jim Cramer’s radar recently. A caller’s top five holdings were ...